marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2025-Q2
added 08-14-2025
SCWorx Corp. EPS Ratio 2011-2025 | WORX
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio SCWorx Corp.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.78 | -3.86 | -0.15 | -0.36 | -0.82 | -1.81 | -0.09 | -1.12 | -0.75 | -0.07 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.07 | -3.86 | -0.981 |
Quarterly EPS Ratio SCWorx Corp.
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.46 | -0.25 | - | -0.27 | -0.26 | -0.14 | - | -0.76 | -0.17 | -0.46 | - | -0.03 | -0.05 | -0.06 | - | -0.09 | -0.12 | -0.07 | - | -0.29 | -0.41 | -0.15 | - | -0.1 | -0.38 | -1.27 | - | -0.08 | -0.55 | -0.31 | - | -0.23 | -0.24 | -0.25 | - | -0.11 | -0.51 | -0.02 | - | -0.01 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.01 | -1.27 | -0.27 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Health information services industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Computer Programs and Systems
CPSI
|
-3.15 | $ 9.25 | 4.4 % | $ 133 M |  USA |
 |
Covetrus
CVET
|
-0.39 | $ 20.99 | - | $ 2.94 B | USA |
 |
NantHealth
NH
|
-8.8 | $ 1.35 | -46.64 % | $ 10.4 M | USA |
 |
Cerner Corporation
CERN
|
1.86 | $ 94.92 | - | $ 27.9 B | USA |
 |
Change Healthcare
CHNG
|
-0.18 | $ 27.49 | - | $ 9.03 B | USA |
 |
R1 RCM
RCM
|
-1.86 | $ 14.31 | - | $ 3.81 B | USA |
 |
1Life Healthcare
ONEM
|
-1.64 | $ 16.47 | - | $ 3.37 B | USA |
 |
Signify Health
SGFY
|
-3.27 | $ 30.49 | -0.02 % | $ 7.21 B | - |
 |
NextGen Healthcare
NXGN
|
0.14 | $ 23.94 | - | $ 1.6 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-6.07 | $ 10.5 | - | $ 255 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
1.03 | $ 6.81 | -10.39 % | $ 886 M | USA |
 |
MTBC
MTBC
|
-0.28 | $ 3.43 | -0.58 % | $ 51.7 M | USA |
 |
HealthStream
HSTM
|
0.66 | $ 25.83 | -0.54 % | $ 785 M | USA |
 |
GoodRx Holdings
GDRX
|
0.04 | $ 3.66 | -2.92 % | $ 1.41 B | USA |
 |
HealthEquity
HQY
|
0.65 | $ 95.15 | -1.06 % | $ 8.14 B | USA |
 |
Health Catalyst
HCAT
|
-1.15 | $ 3.38 | -2.31 % | $ 203 M | USA |
 |
iCAD
ICAD
|
-0.21 | $ 3.87 | - | $ 102 M | USA |
 |
American Well Corporation
AMWL
|
-13.9 | $ 5.34 | -3.26 % | $ 80.1 M | USA |
 |
Evolent Health
EVH
|
-0.2 | $ 7.41 | -3.01 % | $ 694 M | USA |
 |
Omnicell
OMCL
|
0.27 | $ 29.94 | -1.96 % | $ 1.38 B | USA |
 |
Progyny
PGNY
|
0.12 | $ 19.23 | -1.54 % | $ 1.65 B | USA |
 |
Akerna Corp.
KERN
|
-0.51 | $ 6.27 | - | $ 161 M | USA |
 |
10x Genomics
TXG
|
-2.18 | $ 13.34 | -1.84 % | $ 1.56 B | USA |
 |
Zhongchao
ZCMD
|
-0.12 | $ 0.71 | 0.28 % | $ 3.7 M |  China |
 |
OptimizeRx Corporation
OPRX
|
-1.03 | $ 21.04 | 0.77 % | $ 360 M | USA |
 |
Phreesia
PHR
|
-2.51 | $ 23.41 | -0.26 % | $ 1.28 B | USA |
 |
Premier
PINC
|
0.22 | $ 28.18 | 0.28 % | $ 2.32 B | USA |
 |
Accolade
ACCD
|
-1.72 | $ 7.03 | 0.29 % | $ 206 M | USA |
 |
Streamline Health Solutions
STRM
|
-2.53 | $ 5.33 | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
-5.87 | $ 8.36 | -7.21 % | $ 1.43 B | USA |
 |
Schrödinger
SDGR
|
-2.57 | $ 21.77 | -1.8 % | $ 1.58 B | USA |
 |
Veeva Systems
VEEV
|
3.27 | $ 291.35 | -1.42 % | $ 46.8 B | - |